| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 401 |
| 1 | ECULIZUMAB | 102 |
| 2 | ONDANSETRON HYDROCHLORIDE | 90 |
| 3 | ONDANSETRON | 85 |
| 4 | ONDANSETRON TABLETS | 85 |
| 5 | DEXAMETHASONE | 81 |
| 6 | DEXAMETHASONE 1.5 MG | 81 |
| 7 | FUROSEMIDE | 79 |
| 8 | ACETAMINOPHEN | 71 |
| 9 | AZACITIDINE | 71 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NARSOPLIMAB | 1 | 0.0476 |
| 1 | OBECABTAGENE AUTOLEUCEL | 2 | 0.0282 |
| 2 | CEDAZURIDINE AND DECITABINE | 18 | 0.0184 |
| 3 | REVUMENIB | 16 | 0.0155 |
| 4 | COLLOIDAL SILVER | 1 | 0.0116 |
| 5 | OLUTASIDENIB | 3 | 0.0104 |
| 6 | POLYETHYLENE GLYCOL, UNSPECIFIED | 1 | 0.0100 |
| 7 | TELAVANCIN HYDROCHLORIDE | 1 | 0.0083 |
| 8 | SODIUM ACETATE | 2 | 0.0070 |
| 9 | VENETOCLAX | 401 | 0.0064 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 401 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 163 |
| 2 | Corticosteroid [EPC] | 142 |
| 3 | Alkylating Drug [EPC] | 120 |
| 4 | Complement Inhibitor [EPC] | 102 |
| 5 | Azole Antifungal [EPC] | 97 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 91 |
| 7 | Loop Diuretic [EPC] | 84 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 77 |
| 9 | Proton Pump Inhibitor [EPC] | 71 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 401 | 0.0064 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 8 | 0.0037 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 7 | 0.0021 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 5 | 0.0021 |
| 4 | Antifibrinolytic Agent [EPC] | 20 | 0.0020 |
| 5 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 6 | Complement Inhibitor [EPC] | 102 | 0.0018 |
| 7 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 8 | Asparagine-specific Enzyme [EPC] | 16 | 0.0012 |
| 9 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |